Revenue Summary of Novo Nordisk A/S

Novo Nordisk A/S's latest annual revenue in 2023 was 232.26 Billion DKK , up 31.26% from previous year.
Novo Nordisk A/S's latest quarterly revenue in 2024 Q2 was 68.06 Billion DKK , up 4.15% from previous quarter.
Novo Nordisk A/S reported a annual revenue of 176.95 Billion DKK in annual revenue 2022, up 25.68% from previous year.
Novo Nordisk A/S reported a annual revenue of 140.8 Billion DKK in annual revenue 2021, up 10.91% from previous year.
Novo Nordisk A/S reported a quarterly revenue of 65.34 Billion DKK for 2024 Q1, down -0.78% from previous quarter.
Novo Nordisk A/S reported a quarterly revenue of 54.3 Billion DKK for 2023 Q2, up 1.75% from previous quarter.

Annual Revenue Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Revenue of Novo Nordisk A/S (2023 - 1989)

Year	Revenue	Revenue Growth
2023	232.26 Billion DKK	31.26%
2022	176.95 Billion DKK	25.68%
2021	140.8 Billion DKK	10.91%
2020	126.94 Billion DKK	4.04%
2019	122.02 Billion DKK	9.11%
2018	111.83 Billion DKK	0.12%
2017	111.69 Billion DKK	-0.08%
2016	111.78 Billion DKK	3.57%
2015	107.92 Billion DKK	21.53%
2014	88.8 Billion DKK	6.26%
2013	83.57 Billion DKK	7.11%
2012	78.02 Billion DKK	17.6%
2011	66.34 Billion DKK	9.16%
2010	60.77 Billion DKK	18.99%
2009	51.07 Billion DKK	11.85%
2008	45.66 Billion DKK	9.02%
2007	41.88 Billion DKK	8.09%
2006	38.75 Billion DKK	14.94%
2005	33.71 Billion DKK	15.33%
2004	29.23 Billion DKK	9.85%
2003	26.61 Billion DKK	5.8%
2002	25.15 Billion DKK	6.06%
2001	23.71 Billion DKK	13.94%
2000	20.81 Billion DKK	-0.62%
1999	20.94 Billion DKK	16.94%
1998	17.9 Billion DKK	5.45%
1997	16.98 Billion DKK	13.96%
1996	14.9 Billion DKK	8.68%
1995	13.71 Billion DKK	1.44%
1994	13.51 Billion DKK	2.83%
1993	13.14 Billion DKK	23.19%
1992	10.67 Billion DKK	8.56%
1991	9.82 Billion DKK	17.97%
1990	8.33 Billion DKK	9.36%
1989	7.61 Billion DKK	35.34%

Year	Revenue	Revenue Growth
2024 Q2	68.06 Billion DKK	4.15%
2024 Q1	65.34 Billion DKK	-0.78%
2023 Q2	54.3 Billion DKK	1.75%
2023 Q1	53.36 Billion DKK	10.97%
2023 FY	232.26 Billion DKK	31.26%
2023 Q4	65.86 Billion DKK	12.14%
2023 Q3	58.73 Billion DKK	8.16%
2022 Q1	42.03 Billion DKK	9.65%
2022 Q4	48.09 Billion DKK	5.54%
2022 FY	176.95 Billion DKK	25.68%
2022 Q2	41.26 Billion DKK	-1.82%
2022 Q3	45.56 Billion DKK	10.42%
2021 FY	140.8 Billion DKK	10.91%
2021 Q2	33.04 Billion DKK	-2.26%
2021 Q4	38.33 Billion DKK	7.61%
2021 Q1	33.8 Billion DKK	5.18%
2021 Q3	35.62 Billion DKK	7.81%
2020 Q1	33.87 Billion DKK	4.5%
2020 FY	126.94 Billion DKK	4.04%
2020 Q4	32.13 Billion DKK	3.92%
2020 Q3	30.92 Billion DKK	3.07%
2020 Q2	30 Billion DKK	-11.42%
2019 Q3	30.27 Billion DKK	0.8%
2019 Q1	29.29 Billion DKK	-1.48%
2019 Q2	30.03 Billion DKK	2.54%
2019 FY	122.02 Billion DKK	9.11%
2019 Q4	32.41 Billion DKK	7.07%
2018 Q1	26.93 Billion DKK	-3.79%
2018 Q2	27.4 Billion DKK	1.77%
2018 Q3	27.76 Billion DKK	1.3%
2018 FY	111.83 Billion DKK	0.12%
2018 Q4	29.73 Billion DKK	7.1%
2017 Q2	28.63 Billion DKK	0.65%
2017 FY	111.69 Billion DKK	-0.08%
2017 Q4	27.99 Billion DKK	5.18%
2017 Q1	28.45 Billion DKK	-3.79%
2017 Q3	26.61 Billion DKK	-7.07%
2016 Q4	29.57 Billion DKK	7.39%
2016 FY	111.78 Billion DKK	3.57%
2016 Q2	27.45 Billion DKK	0.91%
2016 Q3	27.53 Billion DKK	0.28%
2016 Q1	27.21 Billion DKK	-5.76%
2015 FY	107.92 Billion DKK	21.53%
2015 Q1	25.2 Billion DKK	2.5%
2015 Q2	27.05 Billion DKK	7.38%
2015 Q3	26.79 Billion DKK	-0.99%
2015 Q4	28.87 Billion DKK	7.78%
2014 Q4	24.58 Billion DKK	10.5%
2014 FY	88.8 Billion DKK	6.26%
2014 Q1	20.34 Billion DKK	-6.24%
2014 Q3	22.24 Billion DKK	2.87%
2014 Q2	21.62 Billion DKK	6.32%
2013 Q4	21.69 Billion DKK	5.79%
2013 FY	83.57 Billion DKK	7.11%
2013 Q3	20.51 Billion DKK	-4.06%
2013 Q2	21.38 Billion DKK	6.99%
2013 Q1	19.98 Billion DKK	-4.67%
2012 Q4	20.96 Billion DKK	5.63%
2012 FY	78.02 Billion DKK	17.6%
2012 Q3	19.84 Billion DKK	1.94%
2012 Q2	19.46 Billion DKK	9.67%
2012 Q1	17.75 Billion DKK	-2.04%
2011 Q2	16 Billion DKK	1.96%
2011 Q4	18.12 Billion DKK	9.61%
2011 FY	66.34 Billion DKK	9.16%
2011 Q1	15.69 Billion DKK	-2.67%
2011 Q3	16.53 Billion DKK	3.32%
2010 FY	60.77 Billion DKK	18.99%
2010 Q4	16.12 Billion DKK	3.47%
2010 Q3	15.58 Billion DKK	1.23%
2010 Q1	13.67 Billion DKK	4.69%
2010 Q2	15.39 Billion DKK	12.58%
2009 FY	51.07 Billion DKK	11.85%
2009 Q3	12.51 Billion DKK	-3.72%
2009 Q2	13 Billion DKK	4.02%
2009 Q1	12.49 Billion DKK	-1.77%
2009 Q4	13.06 Billion DKK	4.35%
2008 FY	45.66 Billion DKK	9.02%
2008 Q3	11.23 Billion DKK	1.11%
2008 Q2	11.11 Billion DKK	4.8%
2008 Q1	10.6 Billion DKK	-3.73%
2008 Q4	12.72 Billion DKK	13.23%
2007 Q4	11.01 Billion DKK	4.92%
2007 Q1	9.81 Billion DKK	-6.35%
2007 Q2	10.56 Billion DKK	7.64%
2007 FY	41.88 Billion DKK	8.09%
2007 Q3	10.49 Billion DKK	-0.65%
2006 FY	38.75 Billion DKK	14.94%
2006 Q4	10.48 Billion DKK	9.34%
2006 Q3	9.58 Billion DKK	-1.48%
2006 Q2	9.73 Billion DKK	8.72%
2006 Q1	8.95 Billion DKK	-4.75%
2005 Q3	8.78 Billion DKK	6.26%
2005 FY	33.71 Billion DKK	15.33%
2005 Q4	9.39 Billion DKK	6.91%
2005 Q1	7.26 Billion DKK	-9.2%
2005 Q2	8.27 Billion DKK	13.86%
2004 Q1	6.52 Billion DKK	-10.06%
2004 FY	29.23 Billion DKK	9.85%
2004 Q4	8 Billion DKK	7.21%
2004 Q3	7.46 Billion DKK	8.19%
2004 Q2	6.89 Billion DKK	5.71%
2003 Q4	7.25 Billion DKK	8.07%
2003 Q2	6.48 Billion DKK	6.45%
2003 FY	26.61 Billion DKK	5.8%
2003 Q3	6.71 Billion DKK	3.56%
2003 Q1	6.09 Billion DKK	-8.86%
2002 FY	25.15 Billion DKK	6.06%
2002 Q4	6.68 Billion DKK	3.67%
2002 Q3	6.44 Billion DKK	22.11%
2002 Q1	6.02 Billion DKK	-7.42%
2002 Q2	5.27 Billion DKK	-12.32%
2001 Q2	5.74 Billion DKK	7.47%
2001 Q1	5.34 Billion DKK	146.84%
2001 Q4	6.5 Billion DKK	-2.24%
2001 FY	23.71 Billion DKK	13.94%
2001 Q3	6.65 Billion DKK	15.78%
2000 FY	20.81 Billion DKK	-0.62%
2000 Q2	6.48 Billion DKK	16.57%
2000 Q3	15.34 Billion DKK	136.62%
2000 Q4	2.16 Billion DKK	-85.88%
2000 Q1	5.56 Billion DKK	0.01%
1999 Q2	5.02 Billion DKK	8.45%
1999 Q4	5.56 Billion DKK	-4.48%
1999 Q3	5.82 Billion DKK	15.94%
1999 Q1	4.63 Billion DKK	-5.0%
1999 FY	20.94 Billion DKK	16.94%
1998 Q1	4.19 Billion DKK	-10.56%
1998 FY	17.9 Billion DKK	5.45%
1998 Q3	5.03 Billion DKK	10.22%
1998 Q4	4.87 Billion DKK	-3.17%
1998 Q2	4.56 Billion DKK	8.95%
1997 FY	16.98 Billion DKK	13.96%
1997 Q4	4.68 Billion DKK	8.61%
1997 Q1	3.62 Billion DKK	-13.67%
1997 Q2	4.12 Billion DKK	13.72%
1997 Q3	4.31 Billion DKK	4.63%
1996 Q3	3.66 Billion DKK	4.6%
1996 Q1	3.43 Billion DKK	0.7%
1996 FY	14.9 Billion DKK	8.68%
1996 Q2	3.5 Billion DKK	2.12%
1996 Q4	4.2 Billion DKK	14.51%
1995 Q4	3.41 Billion DKK	6.0%
1995 FY	13.71 Billion DKK	1.44%
1995 Q3	3.21 Billion DKK	-9.94%
1995 Q2	3.57 Billion DKK	6.01%
1995 Q1	3.37 Billion DKK	-5.24%
1994 Q2	3.42 Billion DKK	10.02%
1994 Q4	3.55 Billion DKK	5.4%
1994 FY	13.51 Billion DKK	2.83%
1994 Q1	3.11 Billion DKK	-26.64%
1994 Q3	3.37 Billion DKK	-1.4%
1993 FY	13.14 Billion DKK	23.19%
1993 Q4	4.24 Billion DKK	35.46%
1993 Q1	2.62 Billion DKK	-3.24%
1993 Q2	3 Billion DKK	14.37%
1993 Q3	3.13 Billion DKK	4.25%
1992 FY	10.67 Billion DKK	8.56%
1992 Q4	2.71 Billion DKK	5.79%
1992 Q3	2.56 Billion DKK	-8.67%
1992 Q2	2.8 Billion DKK	5.54%
1992 Q1	2.66 Billion DKK	-9.6%
1991 Q4	2.94 Billion DKK	23.05%
1991 FY	9.82 Billion DKK	17.97%
1991 Q2	2.24 Billion DKK	-1.2%
1991 Q1	2.27 Billion DKK	-2.13%
1991 Q3	2.39 Billion DKK	6.4%
1990 Q1	1.94 Billion DKK	-9.53%
1990 FY	8.33 Billion DKK	9.36%
1990 Q4	2.32 Billion DKK	14.61%
1990 Q3	2.02 Billion DKK	-0.11%
1990 Q2	2.03 Billion DKK	4.7%
1989 Q3	1.74 Billion DKK	-0.53%
1989 Q1	1.97 Billion DKK	20.78%
1989 FY	7.61 Billion DKK	35.34%
1989 Q4	2.14 Billion DKK	22.72%
1989 Q2	1.75 Billion DKK	-11.07%

Peer Revenue Comparison of Novo Nordisk A/S

Name	Revenue	Revenue Difference
ALK-Abelló A/S	4.82 Billion DKK	-4714.697%
Bavarian Nordic A/S	7.05 Billion DKK	-3191.063%
Genmab A/S	16.47 Billion DKK	-1309.864%
Gubra A/S	205 Million DKK	-113195.285%
Orphazyme A/S	- DKK	-Infinity%
Pharma Equity Group A/S	- DKK	-Infinity%
Zealand Pharma A/S	342.78 Million DKK	-67656.456%

Global Stocks Search

Novo Nordisk A/S (NOVO-B.CO)

Revenue Summary of Novo Nordisk A/S

Annual Revenue Chart of Novo Nordisk A/S (2023 - 1989)

Historical Annual Revenue of Novo Nordisk A/S (2023 - 1989)

Peer Revenue Comparison of Novo Nordisk A/S